Central Nervous System Reports

Arrowhead Releases New Report Assessing State of Personalized Medicine Market - read more -

New Reports & Conferences eNewsletter

Featured Report

Personalized Medicine 2010

Assessing the Opportunities and Challenges in Commercializing Companion Diagnostics and Targeted Therapies

The era of Personalized Medicine is set to revolutionize the healthcare industry. As our knowledge of genetics and molecular biology rapidly expands, a personalized approach to medical care is becoming increasingly important. Not only does this paradigm promise to improve an individual’s treatment outcome and reduce healthcare expenditure, personalized medicine is set to transform the pharmaceutical/biotechnology and companion diagnostic markets.

- read more -

Central Nervous System Reports

Traumatic Brain Injury

R&D Pipeline Assessment and Market Prospects

Traumatic brain injury (TBI), an acquired damage to the brain that is typically caused by external traumas has been called a silent epidemic. TBI has emerged as the leading cause of central nervous system impairment, ahead of traumatic spinal cord injury.

The Global Pain Therapeutics Market, 3rd Edition: Market Analysis, R&D Pipelines and Competitive Landscape

| Print |

One in five people suffer from moderate to severe chronic pain, and one in three is unable or less able to maintain an independent lifestyle due to their pain. Between 50 and 60 percent of people with chronic pain are less able or unable to exercise, sleep normally, perform household chores, attend social activities, drive a car, or walk.
Read more...

The Global Market and Future Outlook for Neurodegenerative Disorder Therapies 2007

With a market size of US$14.5 billion in 2005 and an anticipated value of US$16.5 billion in 2006, the neurodegenerative market represents a valuable, fast-growing opportunity in the pharma/biotech industry.
Read more...